Fig 1.
Algorithm to treatment of HLA-B27 associated uveitis.
*decrease in number of recurrences.
Table 1.
Epidemiologic and ophthalmologic characteristics of patients with HLA-B27-associated uveitis.
Table 2.
Systemic treatments of patients with HLA-B27-associated uveitis.
Fig 2.
Flowchart to treatment of HLA-B27 associated uveitis.
Fig 3.
Uveitis relapse rate per year in patients with uveitis recurrences treated with sulfasalazine or methotrexate.
Table 3.
Adverse events in patients with HLA-B27-associated uveitis receiving systemic treatments.